These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3139705)

  • 1. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.
    Rosenqvist E; Harthug S; Frøholm LO; Høiby EA; Bøvre K; Zollinger WD
    J Clin Microbiol; 1988 Aug; 26(8):1543-8. PubMed ID: 3139705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.
    Wedege E; Høiby EA; Rosenqvist E; Bjune G
    Infect Immun; 1998 Jul; 66(7):3223-31. PubMed ID: 9632589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen.
    Harthug S; Rosenqvist E; Høiby EA; Gedde-Dahl TW; Frøholm LO
    J Clin Microbiol; 1986 Dec; 24(6):947-53. PubMed ID: 3097068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum opsonins to group B meningococci.
    Sjursen H; Bjerknes R; Halstensen A; Naess A; Frøholm LO; Rosenqvist E; Solberg CO
    Acta Pathol Microbiol Immunol Scand C; 1987 Dec; 95(6):283-9. PubMed ID: 3126623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccine.
    Frasch CE; Zahradnik JM; Wang LY; Mocca LF; Tsai CM
    J Infect Dis; 1988 Oct; 158(4):710-8. PubMed ID: 3139776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination.
    Sjursen H; Wedege E; Rosenqvist E; Naess A; Halstensen A; Matre R; Solberg CO
    APMIS; 1990 Dec; 98(12):1061-9. PubMed ID: 2126441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease.
    Guttormsen HK; Wetzler LM; Naess A
    Infect Immun; 1993 Nov; 61(11):4734-42. PubMed ID: 8406872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.
    Rosenqvist E; Høiby EA; Wedege E; Bryn K; Kolberg J; Klem A; Rønnild E; Bjune G; Nøkleby H
    Infect Immun; 1995 Dec; 63(12):4642-52. PubMed ID: 7591118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
    Skevakis L; Frasch CE; Zahradnik JM; Dolin R
    J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.
    Naess LM; Aarvak T; Aase A; Oftung F; Høiby EA; Sandin R; Michaelsen TE
    Vaccine; 1999 Feb; 17(7-8):754-64. PubMed ID: 10067680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
    Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
    J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination.
    Mandrell RE; Zollinger WD
    Infect Immun; 1989 May; 57(5):1590-8. PubMed ID: 2468608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.
    Söderström C; Braconier JH; Käyhty H; Sjöholm AG; Thuresson B
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):220-4. PubMed ID: 2496990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica.
    Kremastinou J; Tzanakaki G; Pagalis A; Theodondou M; Weir DM; Blackwell CC
    FEMS Immunol Med Microbiol; 1999 May; 24(1):73-8. PubMed ID: 10340715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine.
    Rosenqvist E; Tjade T; Frøholm LO; Frasch CE
    NIPH Ann; 1983 Dec; 6(2):139-49. PubMed ID: 6427704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine.
    Wedege E; Michaelsen TE
    J Clin Microbiol; 1987 Aug; 25(8):1349-53. PubMed ID: 3114315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy.
    Milagres LG; Ramos SR; Sacchi CT; Melles CE; Vieira VS; Sato H; Brito GS; Moraes JC; Frasch CE
    Infect Immun; 1994 Oct; 62(10):4419-24. PubMed ID: 7927704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
    Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
    Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting.
    Wedege E; Frøholm LO
    Infect Immun; 1986 Feb; 51(2):571-8. PubMed ID: 3002987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.